Diamondback Peripheral
Payments companies reported to CMS as associated with Diamondback Peripheral. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Diamondback Peripheral, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Diamondback Peripheral
These are the largest totals companies reported as associated with Diamondback Peripheral. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rajiv Swamy | Sanford, NC | Interventional Cardiology | $40,036.17 |
| Justin Ratcliffe | Brooklyn, NY | Interventional Cardiology | $31,756.96 |
| Joseph Puma | New York, NY | Interventional Cardiology | $29,453.99 |
| Michael Siah | Dallas, TX | Vascular Surgery | $16,341.60 |
| Matthew Whitbeck | Coon Rapids, MN | Cardiovascular Disease | $15,996.23 |
| Jon George | Philadelphia, PA | Interventional Cardiology | $15,572.25 |
| Amr El-Sergany | Aiea, HI | Vascular Surgery | $12,681.39 |
| Vinay Satwah | Greenbelt, MD | Interventional Cardiology | $12,641.49 |
| George Pliagas | Las Vegas, NV | Vascular Surgery | $11,967.77 |
| Ankur Lodha | Lafayette, LA | Interventional Cardiology | $10,608.26 |
Prescribed Diamondback Peripheral?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.